Myristic Acid

Myristic Acid

SCHEMBL8885381

CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)CO.CCCCCCCCCCCCCC(=O)O

nearest known ligand 0.74

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.74
DUSP3 P51452 1/20 0.74
MEN1 O00255 1/20 0.74
KMT2A Q03164 1/20 0.74
LMNA P02545 1/20 0.74
DGKA P23743 1/20 0.64
MAPT P10636 1/20 0.56
FFAR4 Q5NUL3 1/20 0.55
FFAR1 O14842 1/20 0.55
FAAH O00519 4/20 0.54
PRKCA P17252 3/20 0.51
ENPP2 Q13822 2/20 0.51
PRKCE Q02156 1/20 0.51
PRKCQ Q04759 1/20 0.51
PRKCD Q05655 1/20 0.51
LPAR6 P43657 1/20 0.51
LPAR1 Q92633 1/20 0.51
LPAR4 Q99677 1/20 0.51
LPAR5 Q9H1C0 1/20 0.51
LPAR2 Q9HBW0 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Stearic Acid SCHEMBL30063427 1.00 KDM4E (0.74) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL29791959 1.00 KDM4E (0.74) KDM4EDUSP3MEN1KMT2ALMNA
Glyceryl Monostearate SCHEMBL16694502 1.00 KDM4E (0.74) KDM4EDUSP3MEN1KMT2ALMNA
Palmitic Acid SCHEMBL6466526 0.95 KDM4E (0.67) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL30923587 0.95 KDM4E (0.63) KDM4EDUSP3MEN1KMT2ALMNA
Glyceryl Monostearate SCHEMBL28989952 0.95 LMNA (0.82) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL28762308 0.95 KDM4E (0.63) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL30099173 0.95 KDM4E (0.63) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL1695888 0.95 KDM4E (0.63) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL579964 0.95 KDM4E (0.63) KDM4EDUSP3MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118986755-A High-stability multi-encapsulated hinokitiol liposome and preparation method and application thereof 弘知生物科技(浙江)有限公司 2024-11-22 CN claimed
US-12409121-B2 Formulations and methods for preparing stable cosmetic compositions Spinart, LLC (US) 2025-09-09 US disclosed
EP-4279055-B1 METHOD FOR PRODUCING SOLID POWDER COSMETIC KAO CORP (JP) 2025-08-20 EP disclosed
US-20250221899-A1 COSMETIC IWASE COSFA CO., LTD. (JP) 2025-07-10 US disclosed
EP-4570322-A1 OIL-IN-WATER-TYPE EMULSION COMPOSITION Kao Corporation (JP) 2025-06-18 EP disclosed
WO-2025085434-A1 FORMULATIONS TO RESTORE AND ENHANCE THE SKIN BARRIER COLORESCIENCE, INC. (US) 2025-04-24 WO disclosed
US-20250064709-A1 COMPOSITION AND CELLULOSE DERIVATIVE DAICEL CORPORATION (JP) 2025-02-27 US disclosed
EP-4506037-A1 COSMETIC Iwase Cosfa Co., Ltd. (JP) 2025-02-12 EP disclosed
CN-118986755-A High-stability multi-encapsulated hinokitiol liposome and preparation method and application thereof 弘知生物科技(浙江)有限公司 2024-11-22 CN disclosed
EP-4442245-A1 COMPOSITION AND CELLULOSE DERIVATIVE Daicel Corporation (JP) 2024-10-09 EP disclosed
US-20230310280-A1 SOLID HAIR CONDITIONING AGENT COMPOSITION MAX CO., LTD. (JP) 2023-10-05 US disclosed
US-20220370338-A1 SKIN CARE FORMULATIONS COLORESCIENCE, INC. 2022-11-24 US disclosed
US-11433020-B2 Brightening skin care serums COLORESCIENCE, INC. (US) 2022-09-06 US disclosed
EP-4046623-A1 WATER-IN-OIL EMULSION COSMETIC Kao Corporation (JP) 2022-08-24 EP disclosed
EP-4019091-A1 SOLID HAIR CONDITIONING AGENT COMPOSITION Max Co., Ltd. (JP) 2022-06-29 EP disclosed
US-11351110-B2 Silicone-free cosmetic compositions Thomas, Kirsten Elizabeth (US) 2022-06-07 US disclosed
EP-3965724-A1 FORMULATIONS AND METHODS FOR PREPARING STABLE COSMETIC COMPOSITIONS Spinart, LLC (US) 2022-03-16 EP disclosed
CN-114040746-A Oil-in-water type cleansing cosmetic 陶氏东丽株式会社 2022-02-11 CN disclosed
EP-0531684-B1 Detergent composition KAO CORP (JP) 1997-10-08 EP disclosed
EP-0531684-A1 Detergent composition KAO CORPORATION (JP) 1993-03-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230310280-A1 SOLID HAIR CONDITIONING AGENT COMPOSITION SGMS1, SGMS2, SPTLC1 KDM4E 3265/4885DUSP3 4514/4885MEN1 3887/4885
US-20250064709-A1 COMPOSITION AND CELLULOSE DERIVATIVE GHDC, MLEC, MUS81 KDM4E 994/4885DUSP3 4717/4885MEN1 1076/4885
US-12409121-B2 Formulations and methods for preparing stable cosmetic compositions CUTA, ARG1, ODC1 KDM4E 1230/4885DUSP3 2162/4885MEN1 1275/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.